drugset / Trial / NCT02422368
The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
ASTED (Antioxidant Supplements for TED) trial is an investigator-initiated, randomized, triple masked, clinical trial of a selected combination of vitamins and minerals versus placebo in patients with moderate to severe thyroid eye disease. The trial has a parallel-arm design.
Timeline
- Start
- 2022-09-01
- Primary completion
- 2024-06
- Completion
- 2024-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Antioxidant Supplements for Thyroid Eye Disease | Unknown | — | — |
| Comparator | Methylprednisolone | Other / unclassified | 0.7 mg/kg | — |